Table 2 Correlation between the 4-year logMAR BCVA and studied parameters in the non-PM and PM groups.
Non-PM group (n = 19) | PM group (n = 99) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Univariable analysis | Multivariable analysis | Univariable analysis | Multivariable analysis | ||||||
P | r | P | β | P | r | P | β | ||
Baseline parameters | Sex (1, male; 2, female) | 0.18 | − 0.33 | – | – | 0.11 | 0.16 | – | – |
Age | 0.98 | − 0.01 | – | – | 0.11 | 0.16 | – | – | |
AL | 0.06 | − 0.44 | 0.15 | − 0.31 | 0.63 | 0.16 | – | – | |
LogMAR BCVA | 0.01* | − 0.62 | 0.047* | 0.46 | < 0.001* | 0.59 | < 0.001* | 0.59 | |
MNV location (1, extrafoveal; 2, juxtafoveal; 3, foveal) | 0.44 | 0.19 | – | – | 0.36 | 0.09 | – | – | |
MNV size | 0.34 | 0.23 | – | – | 0.001* | 0.33 | 0.92 | 0.009 | |
CRT | 0.29 | 0.26 | – | – | 0.22 | 0.12 | – | – | |
CCT | 0.99 | − 0.004 | – | – | 0.47 | − 0.07 | – | – | |
ERM (0, absent; 1, present) | 0.03* | − 0.49 | 0.22 | − 0.27 | 0.80 | − 0.03 | – | – | |
LMH (0, absent; 1, present) | – | – | – | – | – | – | – | – | |
Lens status (1, phakia; 2, pseudophakia or aphakia) | 0.20 | − 0.31 | – | – | 0.91 | − 0.01 | – | – | |
Treatment parameters | The number of injections | 0.10 | 0.39 | – | – | 0.87 | − 0.02 | – | – |
Cataract surgery during the 4-year observation period | 0.87 | − 0.04 | – | – | 0.42 | − 0.08 | – | – | |
